Below is the patient consent for Isotretinoin (widely recognized by the brand name Accutane). You will be enrolled in the iPLEDGE program at your appointment and we will discuss in great detail the risk and benefits of this medication. The iPLEDGE program is a  risk management distribution program mandated by the U.S. Food and Drug Administration.  Under this program, prescribers must be registered and activated with the iPLEDGE Program and can prescribe isotretinoin only to registered patients who meet all the requirements of iPLEDGE. Isotretinoin can be dispensed only by a pharmacy registered and activated with iPLEDGE. Registered and activated pharmacies can only receive isotretinoin from wholesalers registered with the program. Click the link below for more information.